Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP359223.RAGIRMjHC9q3OkC79GBW6lUR-hDNaJUXMcKMQ4u4t5oIA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP359223.RAGIRMjHC9q3OkC79GBW6lUR-hDNaJUXMcKMQ4u4t5oIA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP359223.RAGIRMjHC9q3OkC79GBW6lUR-hDNaJUXMcKMQ4u4t5oIA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP359223.RAGIRMjHC9q3OkC79GBW6lUR-hDNaJUXMcKMQ4u4t5oIA130_provenance.
- befree-2016 importedOn "2016-02-19" NP359223.RAGIRMjHC9q3OkC79GBW6lUR-hDNaJUXMcKMQ4u4t5oIA130_provenance.
- NP359223.RAGIRMjHC9q3OkC79GBW6lUR-hDNaJUXMcKMQ4u4t5oIA130_assertion wasGeneratedBy ECO_0000203 NP359223.RAGIRMjHC9q3OkC79GBW6lUR-hDNaJUXMcKMQ4u4t5oIA130_provenance.
- NP359223.RAGIRMjHC9q3OkC79GBW6lUR-hDNaJUXMcKMQ4u4t5oIA130_assertion wasDerivedFrom befree-2016 NP359223.RAGIRMjHC9q3OkC79GBW6lUR-hDNaJUXMcKMQ4u4t5oIA130_provenance.
- NP359223.RAGIRMjHC9q3OkC79GBW6lUR-hDNaJUXMcKMQ4u4t5oIA130_assertion SIO_000772 12091121 NP359223.RAGIRMjHC9q3OkC79GBW6lUR-hDNaJUXMcKMQ4u4t5oIA130_provenance.
- NP359223.RAGIRMjHC9q3OkC79GBW6lUR-hDNaJUXMcKMQ4u4t5oIA130_assertion evidence source_evidence_literature NP359223.RAGIRMjHC9q3OkC79GBW6lUR-hDNaJUXMcKMQ4u4t5oIA130_provenance.
- NP359223.RAGIRMjHC9q3OkC79GBW6lUR-hDNaJUXMcKMQ4u4t5oIA130_assertion description "[This protective effect mediated by the presence of GSTM1 was even more pronounced within the subset of therapy group B patients at highest clinical risk of treatment failure (B-ALL, disease stage IV, disease stage III with unresected abdominal tumor, and LDH activity > or = 500 U/L).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP359223.RAGIRMjHC9q3OkC79GBW6lUR-hDNaJUXMcKMQ4u4t5oIA130_provenance.